Eli Lilly Revolutionizes Funding Early Stage Life Science - Entrepreneurship Center at UCSF Speaker Series
Darren Carroll, VP of Corporate Business Development, Eli Lilly, will talk about how Lilly is pioneering a new capital efficient model to develop therapeutics by partnering with VC firms and leveraging resources. Rather than build complete companies around a single molecule, Lilly’s VC partners set up virtual structures that can utilize Lilly development and avoid sizable overhead. Darren will talk about this program as well as Lilly Ventures, the company’s corporate venture capital fund.
Created by anisaucsf
600 16th St.
San Francisco, CA 94158
Hot Tickets More »
|10/13||6:30p||San Francisco OneStart Launch|
|12/11||8:00a||Building Health Forum|